Rocuronium
Rocuronium (rocuronium) is a small molecule pharmaceutical. Rocuronium was first approved as Zemuron on 1994-03-17.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Rocuronium (discontinued: Rocuronium, Zemuron)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Rocuronium bromide
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ROCURONIUM BROMIDE | Fresenius Kabi | N-217472 RX | 2025-06-09 | 2 products, RLD, RS |
Show 1 discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| rocuronium | New Drug Application | 2025-07-16 |
| rocuronium bromide | ANDA | 2025-06-09 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
707 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neuromuscular blockade | D019148 | — | — | 2 | 10 | 10 | 49 | 56 | 126 |
| Anesthesia | D000758 | — | — | — | 2 | 11 | 20 | 36 | 68 |
| General anesthesia | D000768 | — | — | 1 | 10 | 14 | 3 | 35 | 62 |
| Postoperative pain | D010149 | — | G89.18 | — | 2 | 3 | 11 | 26 | 41 |
| Muscle relaxation | D009126 | — | — | 2 | 3 | 3 | 9 | 9 | 24 |
| Intratracheal intubation | D007442 | — | — | — | 1 | 1 | 5 | 14 | 21 |
| Delayed emergence from anesthesia | D055191 | — | — | 1 | — | — | 8 | 10 | 19 |
| Postoperative complications | D011183 | — | — | — | — | — | 4 | 13 | 17 |
| Muscle hypotonia | D009123 | — | — | 3 | 1 | 2 | 4 | 8 | 17 |
| Disease | D004194 | EFO_0000408 | R69 | — | 1 | — | 7 | 7 | 15 |
Show 154 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Heart arrest | D006323 | EFO_0009492 | I46 | — | 2 | 1 | — | 2 | 5 |
| Nerve block | D009407 | — | — | — | — | 1 | — | 3 | 4 |
| Replacement arthroplasty knee | D019645 | — | — | — | — | 1 | — | 2 | 3 |
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | — | 1 | — | 2 | 3 |
| Myalgia | D063806 | — | M79.1 | — | — | 1 | — | 2 | 3 |
| Anesthesia and analgesia | D000760 | — | — | — | 1 | 1 | — | 1 | 2 |
| Heart rate | D006339 | EFO_0004326 | — | — | 1 | 1 | — | 1 | 2 |
| Back pain | D001416 | — | M54 | — | — | 1 | — | — | 1 |
| Spinal fusion | D013123 | — | — | — | — | 1 | — | — | 1 |
| Substance-related disorders | D019966 | EFO_0003890 | F13 | — | 1 | 1 | — | — | 1 |
Show 16 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Coronary artery bypass | D001026 | EFO_0003776 | — | — | 1 | — | — | 2 | 3 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | — | 1 | — | — | 1 | 2 |
| Circulating neoplastic cells | D009360 | — | — | — | 1 | — | — | 1 | 2 |
| Out-of-hospital cardiac arrest | D058687 | — | — | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| High-frequency jet ventilation | D006611 | — | — | 1 | — | — | — | — | 1 |
| Head and neck neoplasms | D006258 | — | — | 1 | — | — | — | — | 1 |
| Spinal fractures | D016103 | EFO_0003902 | S12 | 1 | — | — | — | — | 1 |
| Spinal stenosis | D013130 | EFO_0007490 | M48.0 | 1 | — | — | — | — | 1 |
| Craniotomy | D003399 | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Respiratory aspiration | D053120 | EFO_1001839 | — | — | — | — | — | 6 | 6 |
| Acute kidney injury | D058186 | — | N17 | — | — | — | — | 6 | 6 |
| Thyroid diseases | D013959 | — | E00-E07 | — | — | — | — | 6 | 6 |
| Inhalation anesthesia | D000769 | — | — | — | — | — | — | 6 | 6 |
| Hernia | D006547 | — | K40-K46 | — | — | — | — | 5 | 5 |
| Postoperative nausea and vomiting | D020250 | EFO_0004888 | — | — | — | — | — | 5 | 5 |
| Hysterectomy | D007044 | EFO_0003881 | — | — | — | — | — | 4 | 4 |
| Intraoperative complications | D007431 | — | — | — | — | — | — | 4 | 4 |
| Female genital diseases | D005831 | EFO_0009549 | N85 | — | — | — | — | 4 | 4 |
| Pregnancy rate | D018873 | — | — | — | — | — | — | 3 | 3 |
Show 221 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Rocuronium |
| INN | rocuronium bromide |
| Description | Rocuronium bromide is the organic bromide salt of a 5alpha androstane compound having 3alpha-hydroxy-, 17beta-acetoxy-, 2beta-morpholino- and 16beta-N-allyllyrrolidinium substituents. It has a role as a neuromuscular agent and a muscle relaxant. It is an organic bromide salt and a quaternary ammonium salt. It contains a rocuronium. It derives from a hydride of a 5alpha-androstane. |
| Classification | Small molecule |
| Drug class | quaternary ammonium derivatives: neuromuscular blocking agents; quaternary ammonium derivatives: neuromuscular blocking agents |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1 |
Identifiers
| PDB | — |
| CAS-ID | 143558-00-3 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1201244 |
| ChEBI ID | 8884 |
| PubChem CID | 441351 |
| DrugBank | DB00728 |
| UNII ID | I65MW4OFHZ (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 14,074 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
7,705 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use